Xu J, Zheng S L, Hawkins G A, Faith D A, Kelly B, Isaacs S D, Wiley K E, Chang B, Ewing C M, Bujnovszky P, Carpten J D, Bleecker E R, Walsh P C, Trent J M, Meyers D A, Isaacs W B
Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Am J Hum Genet. 2001 Aug;69(2):341-50. doi: 10.1086/321967. Epub 2001 Jul 6.
Multiple lines of evidence have implicated the short arm of chromosome 8 as harboring genes important in prostate carcinogenesis. Although most of this evidence comes from the identification of frequent somatic alterations of 8p loci in prostate cancer cells (e.g., loss of heterozygosity), studies have also suggested a role for 8p genes in mediation of inherited susceptibility to prostate cancer. To further examine this latter possibility, we performed linkage analyses, in 159 pedigrees affected by hereditary prostate cancer (HPC), using 24 markers on the short arm of chromosome 8. In the complete set of families, evidence for prostate cancer linkage was found at 8p22-23, with a peak HLOD of 1.84 (P=.004), and an estimate of the proportion of families linked (alpha) of 0.14, at D8S1130. In the 79 families with average age at diagnosis >65 years, an allele-sharing LOD score of 2.64 (P=.0005) was observed, and six markers spanning a distance of 10 cM had LOD scores >2.0. Interestingly, the small number of Ashkenazi Jewish pedigrees (n=11) analyzed in this study contributed disproportionately to this linkage. Mutation screening in HPC probands and association analyses in case subjects (a group that includes HPC probands and unrelated case subjects) and unaffected control subjects were carried out for the putative prostate cancer-susceptibility gene, PG1, previously localized to the 8p22-23 region. No statistical differences in the allele, genotype, or haplotype frequencies of the SNPs or other sequence variants in the PG1 gene were observed between case and control subjects. However, case subjects demonstrated a trend toward higher homozygous rates of less-frequent alleles in all three PG1 SNPs, and overtransmission of a PG1 variant to case subjects was observed. In summary, these results provide evidence for the existence of a prostate cancer-susceptibility gene at 8p22-23. Evaluation of the PG1 gene and other candidate genes in this area appears warranted.
多项证据表明,8号染色体短臂上存在对前列腺癌发生发展至关重要的基因。尽管大部分证据来自于前列腺癌细胞中8p位点频繁的体细胞改变(如杂合性缺失)的鉴定,但研究也提示8p基因在介导前列腺癌遗传易感性方面发挥作用。为进一步探究后一种可能性,我们在159个受遗传性前列腺癌(HPC)影响的家系中,使用8号染色体短臂上的24个标记进行连锁分析。在所有家系中,在8p22 - 23发现了前列腺癌连锁证据,在D8S1130处最高对数优势(HLOD)为1.84(P = 0.004),估计连锁家系比例(α)为0.14。在诊断平均年龄>65岁的79个家系中,观察到等位基因共享对数优势分数为2.64(P = 0.0005),跨越10厘摩距离的6个标记的对数优势分数>2.0。有趣的是,本研究中分析的少量德系犹太人家系(n = 11)对这种连锁的贡献不成比例。对先前定位于8p22 - 23区域的假定前列腺癌易感基因PG1,在HPC先证者中进行突变筛查,并在病例组(包括HPC先证者和无关病例个体)和未受影响的对照组中进行关联分析。病例组和对照组在PG1基因的单核苷酸多态性(SNP)或其他序列变异的等位基因、基因型或单倍型频率上未观察到统计学差异。然而,病例组在所有三个PG1 SNP中显示出低频等位基因纯合率较高的趋势,并且观察到一个PG1变异向病例组的过度传递。总之,这些结果为8p22 - 23存在前列腺癌易感基因提供了证据。对该区域的PG1基因和其他候选基因进行评估似乎是必要的。